AIP
BIOR

Ameritas Investment Partners’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Ameritas Investment Partners’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed -$1K – 3305
2021
Q1 		$1K Hold
1
– – ﹤0.01% 3092
2020
Q4 		$2K Hold
1
– – ﹤0.01% 3056
2020
Q3 		$3K Buy
+1
New +$2.26K ﹤0.01% 3055

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's BIOR Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2021, closing a stake of 1 share — an estimated $1K sold.

Ameritas Investment Partners first reported a position in BIOR in Q3 2020 and held it in 3 quarters. The position peaked at $3K in Q3 2020. 42 funds tracked by Wall St. Rank hold BIOR as of Q2 2021.

  • Ameritas Investment Partners reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 1 Biora Therapeutics, Inc. Common Stock share in Q2 2021, an estimated $1K.
  • Ameritas Investment Partners first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Ameritas Investment Partners's Biora Therapeutics, Inc. Common Stock position peaked at $3K in Q3 2020.
  • 42 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.